Non-Injection Drug Abuse and HIV/AIDS (R21)

The summary for the Non-Injection Drug Abuse and HIV/AIDS (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Non-Injection Drug Abuse and HIV/AIDS (R21): -Purpose. This Funding Opportunity Announcement (FOA) seeks to understand the contribution of non-injection drug abuse to the acquisition and/or transmission and/or disease progression of HIV/AIDS through use of the R21 mechanism to support new exploratory and developmental research projects. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research or the innovative use of an existing methodology to explore a new scientific area. Specifically, it seeks to: 1) investigate how, where, why, and among whom HIV/AIDS spreads through high-risk sexual behavior associated with non-injection drug use; 2) develop effective prevention interventions and treatment for non-injection drug users at risk for or infected with HIV; and 3) improve accessibility and utilization of evidence-based, integrated care for non-injection drug abuse, risky sexual behavior, and HIV/AIDS and other infectious diseases. The PA will support research employing a range of methodological approaches including basic, clinical, epidemiological, prevention, and treatment studies as well as multidisciplinary research in the biomedical, behavioral, and social sciences to contribute to knowledge in these areas. -Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental (R21) award mechanism: and runs in parallel with an FOA of identical scientific scope, PAS-07-115, that solicits applications under the R01 mechanism and PAS-07-261, that solicits applications under the R03 mechanism. -Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 3-7 projects awarded as a result of this announcement is $2,000,000 for fiscal year 2007 for this FOA and its companion R01 and R03.

Federal Grant Title:	Non-Injection Drug Abuse and HIV/AIDS (R21)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Education
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAS-07-262
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse and Addiction Research Programs
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Dec 21, 2006
Creation Date:	Dec 21, 2006
Archive Date:	Feb 02, 2009
Total Program Funding:	$20,000,000
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal governments (Federally recognized) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Small businesses State governments
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...; • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...; • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...; • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...; • Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...; • Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Agi...